New Horizon develops technology partnership with Prenetics

hina's leading non-invasive colon cancer screening biotech company, New Horizon Health Limited, announced in a signing ceremony that it had entered into an exclusive agreement with Prenetics Limited, a leading genetics and digital health company in Asia and Europe. Under the terms of the agreement, New Horizon will provide a technical transfer to Prenetics for ColoClear. ColoClear, a non-invasive multi-target stool DNA test for colorectal cancer, has been specifically developed for individuals whom are of Asian ethnicity and have been validated through clinical studies to perform at 92% sensitivity in the detection of colon cancer.

Upload Company Info



Chemxpert Demo Video


Dataset Sample


Chemical Name

Synonyms

Molecular Formula

Molecular Weight


To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Innovator

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Market Status

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Indication

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Therapeutic Segment

To Access this information please pay by using "Pay & Download" button.

Pay & Download

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Thank you for your enquiry

Your product will be updated soon in our database


Submit Your Query



Select Any Option



Page loaded in 0.001185 seconds